Speakers - NWC 2025

Abstract

Abstract

Background: The present study relates to a method to treat and detoxify patients with substance use disorder (SUD) utilizing a series of nicotinamide adeninedinucleotide (NAD+) and enkephalinase infusions (NADASE) in subjects at-tending chemical dependency programs.

Objective: The primary objective of the current investigation is to provide some additional clinical evidence to show that NAD+ other amino acids includingd-phenylalanine, glycine and ananylglutamine dipeptide and Myer’s cocktail (Bcomplex) infusions significantly attenuates substance craving behavior and con-comitant psychiatric burden sequalae in poly-drug abusers attending both in-pa-tient and out-patient level of care in a number of chemical dependency programs in orange country.

Methods: At symmetry approximately 1,000 now performed approximately1,000 infusions on 900 patients without any serious side effects pointing to thesafety of this procedure. The study cohort (n = 50) as a subgroup consisted ofhighly addicted poly-drug mixed gender and varied ethnic individuals previously resistant to standard treatment with a range of failed treatment attempts from one to ten. Each patient included in this study received a minimum of 7 infusionsfor an average duration of four weeks. The data includes craving scores, anxiety,depression, and sleep. We utilized likert scales (1 - 10) self-reported responses,accomplished via a counselor to patient structured interview.

Results: In summary considering all fifty subjects using wilcoxon signed rank tests and sign tests, we found the following significance comparing the baselinescores to post outcome scores after NAD infusions; craving scores (P = 1.063E-9); anxiety (P = 5.487E-7); and depression (P = 1.763E-4). There was an improvement trend in the number of sleep hours post infusions, it was non-significant

(Pre 6.28, and post 7.34). Importantly, urine analysis of a standard panel of illicit drugs of abuse during the course of NAD infusions resulted in a subset of 40patients tested at midway during infusions 100% of these patients tested negative.

Conclusion: These annotated notes serve an important function showing patient

to patient similarities and differences and contribute to the emerging literature

concerning NAD efficacy in SUD.